Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
03 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250703696269/en/InnoCare-Announces-Approval-of-Clinical-Trial-of-a-Novel-ADC-ICP-B794-in-China
12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250612180584/en/Data-of-InnoCares-Robust-Hemato-Oncology-Pipelines-Presented-at-the-European-Hematology-Association-EHA-2025-Congress
01 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250601983213/en/Latest-Data-of-InnoCares-Robust-Oncology-Pipelines-Presented-at-the-2025-ASCO-Annual-Meeting
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528355532/en/InnoCare-Announces-Approval-of-Clinical-Trial-of-BCL2-Inhibitor-Mesutoclax-for-Myelodysplastic-Syndromes-in-China
21 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250521528560/en/InnoCare-Announces-the-Approval-of-Minjuvi-Tafasitamab-in-Combination-with-Lenalidomide-for-the-treatment-of-Adult-Patients-with-Relapsed-or-Refractory-Diffuse-Large-B-Cell-Lymphoma-in-China
16 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250515819406/en/InnoCare-Announces-First-Patient-Dosed-in-the-Phase-IIIIII-Clinical-Trial-of-TYK2-Inhibitor-Soficitinib-for-Treatment-of-Vitiligo-in-China
ABOUT THIS PAGE